Puma Biotechnology, Inc. (PBYI)

NASDAQ: PBYI · Real-Time Price · USD

8.83

+0.12 (1.38%)

At close: Aug 14, 2026, 4:00 PM EDT

8.90

+0.07 (0.79%)

After-hours: Aug 14, 2026, 7:36 PM EDT

Puma Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	36.54	29.64	69.22	84.59	76.2	63.13
Short-Term Investments	57.37	67.89	31.75	11.35	4.87	18.98
Cash & Short-Term Investments	93.9	97.53	100.97	95.94	81.07	82.11
Cash Growth	-2.21%	-3.40%	5.24%	18.34%	-1.26%	-12.08%
Accounts Receivable	34.06	53.65	32.01	47.84	40.35	32.53
Other Receivables	-	-	-	-	1.92	-
Receivables	34.06	53.65	32.01	47.84	42.27	32.53
Inventory	13.32	5.52	8.72	7.08	4.53	7.11
Prepaid Expenses	1.6	1.63	1.83	2.48	2.62	8.98
Restricted Cash	-	2.09	-	-	-	8.85
Other Current Assets	2.18	2.27	4.13	2.85	3.79	0.45
Total Current Assets	145.07	162.69	147.66	156.19	134.28	140.02
Property, Plant & Equipment	4.52	5.56	5.09	8.65	12.51	15.77
Other Intangible Assets	36.52	41.39	51.13	60.87	70.61	66.13
Long-Term Deferred Tax Assets	3.83	3.83	7.08	-	-	-
Long-Term Deferred Charges	0.1	0.1	0.1	0.21	-	0.58
Other Long-Term Assets	2.69	2.73	2.27	4.62	4.66	4.09
Total Assets	192.74	216.3	213.33	230.53	222.06	226.59

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.11	5.06	5.51	6.89	6.44	11.17
Accrued Expenses	28.16	35.82	26.07	35.63	32.73	24.03
Current Portion of Long-Term Debt	-	22.52	45.33	34	-	-
Current Portion of Leases	0.45	1.31	5.54	4.8	4.14	3.57
Other Current Liabilities	18.11	16.54	13.66	18.07	34.17	70.81
Total Current Liabilities	49.83	81.25	96.11	99.38	77.48	109.59
Long-Term Debt	-	-	21.72	65.66	98.31	97.09
Long-Term Leases	4.37	4.71	1.49	7.03	11.83	15.98
Other Long-Term Liabilities	-	-	1.88	5.01	12.83	6.38
Total Liabilities	54.19	85.96	121.21	177.09	200.45	229.03

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	1,418	1,414	1,407	1,399	1,388	1,364
Retained Earnings	-1,279	-1,284	-1,315	-1,345	-1,367	-1,367
Comprehensive Income & Other	-0.05	0.04	0.01	-0	-	-0
Shareholders' Equity	138.54	130.34	92.13	53.44	21.61	-2.45
Total Liabilities & Equity	192.74	216.3	213.33	230.53	222.06	226.59

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	4.82	28.55	74.08	111.49	114.28	116.64
Net Cash (Debt)	89.09	68.98	26.88	-15.55	-33.21	-34.54
Net Cash Growth	90.38%	156.60%	-	-	-	-
Net Cash Per Share	1.72	1.36	0.55	-0.33	-0.74	-0.85
Filing Date Shares Outstanding	51.62	50.88	49.61	48.21	46.64	41.33
Total Common Shares Outstanding	51.1	50.41	49.11	47.65	46.35	41.18
Working Capital	95.25	81.43	51.55	56.8	56.8	30.44
Book Value Per Share	2.71	2.59	1.88	1.12	0.47	-0.06
Tangible Book Value	102.02	88.95	40.99	-7.43	-49	-68.57
Tangible Book Value Per Share	2.00	1.76	0.83	-0.16	-1.06	-1.67
Machinery	1.32	2.24	4.6	4.76	4.79	4.84
Leasehold Improvements	1.7	2.55	3.78	3.78	3.78	3.78

SEC Filings: 10-K · 10-Q